ENSG
NASDAQ · Health Care
Ensign Group Inc/The
$182.97
+1.31 (+0.72%)
Financial Highlights (FY 2026)
Revenue
4.96B
Net Income
337.39M
Gross Margin
21.1%
Profit Margin
6.8%
Rev Growth
+18.7%
D/E Ratio
0.06
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 21.1% | 21.1% | 41.2% | 41.2% |
| Operating Margin | 8.4% | 7.6% | 11.7% | 14.0% |
| Profit Margin | 6.8% | 6.5% | 10.8% | 11.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 4.96B | 4.18B | 4.21B | 4.15B |
| Gross Profit | 1.05B | 880.78M | 1.73B | 1.71B |
| Operating Income | 417.23M | 316.40M | 490.49M | 578.58M |
| Net Income | 337.39M | 255.86M | 452.95M | 453.91M |
| Gross Margin | 21.1% | 21.1% | 41.2% | 41.2% |
| Operating Margin | 8.4% | 7.6% | 11.7% | 14.0% |
| Profit Margin | 6.8% | 6.5% | 10.8% | 11.0% |
| Rev Growth | +18.7% | +18.7% | +1.5% | -7.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 315.44M | 315.44M | 3.37B | 3.51B |
| Total Equity | 4.97B | 4.97B | 4.63B | 4.21B |
| D/E Ratio | 0.06 | 0.06 | 0.73 | 0.83 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 519.51M | 415.85M | 812.11M | 863.45M |
| Free Cash Flow | — | — | 544.25M | 422.07M |